Anti-Lung Cancer Agent Discovery and Development: A Review of Cross-Platform Correlation Across in silico, Network Pharmacology, in vitro, and in vivo Assessments
Abstract Lung cancer remains one of the leading causes of cancer-related mortality worldwide, highlighting the urgent need for more effective and clinically translatable therapeutic agents. In recent years, drug discovery strategies integrating computational modeling with experimental validation have gained increasing...